IL6 and lung cancer: 6-OAP inhibited constitutively activated STAT3, suppressed IL-6-induced pSTAT3 (Figure 3), and triggered apoptosis and suppressed migration of lung cancer cells in vitro (Figure 6) and showed potent anti-lung cancer activity in vivo (Figure 6) [20].